APVO Company Profile and Key Details

Q: Who are the executives of APVO?

Dr. Dirk Huebner M.D.Chief Medical OfficerMs. SoYoung Kwon J.D., LL.M.Senior Vice President, Gen. Counsel, Bus. Devel. & Corporation AffairsDr. Jane A. Gross Ph.D.Chief Scientific OfficerMs. Daphne L. TaylorSenior Vice President & Chief Financial OfficerMr. Jeffrey G. Lamothe CAExecutive Vice President & Chief Operating OfficerMr. Marvin L. WhitePres, Chief Executive Officer & Director

NASDAQ : APVO

Aptevo Therapeutics

$6.40

-0.06-0.93%

At Close 4:00 PM

58.64

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Aptevo Therapeutics Inc. (APVO) stock declined over -0.93%, trading at $6.40 on NASDAQ, down from the previous close of $6.46. The stock opened at $6.43, fluctuating between $6.32 and $6.46 in the recent session.

Stock Snapshot

6.46

Prev. Close

10.51M

Market Cap

6.32

Day Low

N/A

P/E Ratio

7758.2

EPS (TTM)

-26.51

Cash Flow per Share

6.43

Open

936.13K

Number of Shares

6.46

Day High

99.2%

Free Float in %

27.62

Book Value

5.4K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 06, 2026	6.49	6.51	6.35	6.40	5.47K
Mar 03, 2026	6.84	7.22	6.45	6.66	25.81K
Mar 02, 2026	7.28	7.31	6.86	7.09	4.88K
Feb 27, 2026	7.11	7.42	7.11	7.32	11.18K
Feb 26, 2026	7.10	7.60	7.08	7.35	26.81K
Feb 25, 2026	6.74	7.20	6.55	7.17	16.44K
Feb 24, 2026	6.43	6.90	6.43	6.88	17.83K
Feb 23, 2026	6.70	6.84	6.30	6.30	28.67K
Feb 20, 2026	6.90	7.10	6.66	6.66	13.6K
Feb 19, 2026	6.75	7.07	6.70	6.98	31.45K
Feb 18, 2026	7.13	7.23	6.67	6.68	18.66K
Feb 17, 2026	7.02	7.70	6.88	7.15	41.87K
Feb 13, 2026	6.60	7.15	6.57	6.71	38.6K
Feb 12, 2026	6.94	7.11	6.40	6.59	38.03K
Feb 11, 2026	6.84	7.16	6.81	6.95	19.23K
Feb 10, 2026	6.83	7.13	6.69	6.98	22.74K
Feb 09, 2026	6.84	7.11	6.66	6.90	14.79K
Feb 06, 2026	6.06	6.84	6.06	6.70	50.82K
Feb 05, 2026	6.30	6.45	5.94	6.01	85.65K
Feb 04, 2026	6.73	6.86	6.30	6.41	33.66K

Contact Details

Seattle, WA 98121

United States

https://www.aptevotherapeutics.com 206 838 0500

About Company

Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelodysplastic syndrome. The company's preclinical candidates also include ALG.APV-527, an investigational bispecific ADAPTIR candidate that features a mechanism of action to target 4-1BB (CD137) and 5T4, a tumor antigen expressed in various types of cancers; and APVO603, a dual agonist bispecific antibody to target 4-1BB and OX40. It also develoes APVO442, a bispecific candidate based on the ADAPTIR-FLEX platform technology to enhance biodistribution of drugs to PSMA positive tumors for treatment of prostate cancer. The company has a collaboration and option agreement with Alligator Bioscience AB to develop ALG.APV-527. Aptevo Therapeutics Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

Stock Peers

REGN

-5.07-0.66%

Regeneron Pharmaceuticals, Inc.$759.86 ARGX

-10.31-1.42%

argenx SE$717.80 UTHR

-6.9-1.42%

United Therapeutics Corporation$478.16 VRTX

-4.13-0.90%

Vertex Pharmaceuticals Incorporated$456.69 MDGL

-6.51-1.48%

Madrigal Pharmaceuticals, Inc.$432.83 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ALNY

0.15+0.05%

Alnylam Pharmaceuticals, Inc.$320.66 PRAX

0.13+0.04%

Praxis Precision Medicines, Inc.$310.71 KRYS

-6.64-2.55%

Krystal Biotech, Inc.$253.69 ASND

3.3+1.39%

Ascendis Pharma A/S$240.65

Frequently Asked Questions

What is the current Aptevo Therapeutics Inc. (APVO) stock price?

Aptevo Therapeutics Inc. (NASDAQ: APVO) stock price is $6.40 in the last trading session. During the trading session, APVO stock reached the peak price of $6.46 while $6.32 was the lowest point it dropped to. The percentage change in APVO stock occurred in the recent session was -0.93% while the dollar amount for the price change in APVO stock was - $0.06.

APVO's industry and sector of operation?

The NASDAQ listed APVO is part of Biotechnology industry that operates in the broader Healthcare sector. Aptevo Therapeutics Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of APVO?

Dr. Dirk Huebner M.D.
Chief Medical Officer
Ms. SoYoung Kwon J.D., LL.M.
Senior Vice President, Gen. Counsel, Bus. Devel. & Corporation Affairs
Dr. Jane A. Gross Ph.D.
Chief Scientific Officer
Ms. Daphne L. Taylor
Senior Vice President & Chief Financial Officer
Mr. Jeffrey G. Lamothe CA
Executive Vice President & Chief Operating Officer
Mr. Marvin L. White
Pres, Chief Executive Officer & Director

How APVO did perform over past 52-week?

APVO's closing price is 7.74% higher than its 52-week low of $5.94 where as its distance from 52-week high of $1,299.60 is -99.51%.

How many employees does APVO have?

Number of APVO employees currently stands at 37.

Link for APVO official website?

Official Website of APVO is: https://www.aptevotherapeutics.com

How do I contact APVO?

APVO could be contacted at phone 206 838 0500 and can also be accessed through its website. APVO operates from 2401 4th Avenue, Seattle, WA 98121, United States.

How many shares of APVO are traded daily?

APVO stock volume for the day was 5.4K shares. The average number of APVO shares traded daily for last 3 months was 184.69K.

What is the market cap of APVO currently?

The market value of APVO currently stands at $10.51M with its latest stock price at $6.40 and 936.13K of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	37
Beta	1.48
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	37
Beta	1.48
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

APVO Company Profile and Key Details

Aptevo Therapeutics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Price Forecast & Outlook

Key Takeaways

Company Overview

Valuation Metrics